“一带一路”背景下中国医药进出口贸易的竞争力分析【摘要】“一带一路”政策是中国顺应当今全球经济发展的趋势，充分利用如今世界大国的良好形象，为全人类打造的经济合作方案，而这也为中国与沿线各国家的医药产业发展寻求最大利益提供了保障。本文通过对“一带一路”政策实施前后两年间中国与沿线各国家的医药贸易数据进行竞争力分析，结合该政策对沿线各国的影响分析，发现中国虽然与沿线国家贸易数额日渐增加，但总体上产业竞争力却在下降，而医药产业更是处于劣势阶段。文章会深入剖析其中的原因，并且为提高医药进出口贸易竞争力发展提供建议。【关键词】医药进出口贸易；一带一路；竞争力The Relation Between One Belt, One Road and the Competitiveness of China's Pharmaceutical Import and Export Trade[Abstract] The "one belt, one road China" policy is a China's economic cooperation plan that is in line with the trend of global economic development and making full use of the good image of the great powers of the world today. It also provides a guarantee for the best interests of China and the development of pharmaceutical industry in various countries along the route. China's China and other countries one after another, one belt, one road, has been used to analyze the competitiveness of China's pharmaceutical trade data in the past two years. The analysis of the impact of the policy on the countries along the border shows that although China's trade volume with the countries along the border is increasing, the overall competitiveness of the industry is declining, while the pharmaceutical industry is at a disadvantage stage. This paper will analyze the reasons and provide suggestions for improving the competitiveness of pharmaceutical import and export trade. [Keywords] Medicine import and export one belt, one road competitiveness目 录 1 绪论........................................................................................
